-
Harmonization or Hindrance? A Strategic Analysis of Divergent National Requirements Under the EU Joint Clinical Assessment
Sep 9, 2025, 16:22 PM -
Is Protocolized Stopping Lifelong Therapy With Eculizumab With Disease Monitoring and Retreatment for Eligible Atypical Hemolytic Uremic Syndrome (aHUS) Patients Cost-Effective? An Economic Evaluation of the SETS aHUS Trial
Sep 9, 2025, 16:22 PM -
Persistence to Basal Insulin and Economic Outcomes Among Patients With Type 2 Diabetes: A Retrospective Analysis Using Electronic Health Records in England
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Etrasimod, Ozanimod, and Adalimumab Compared to Infliximab in Treatment-Naive Patients With Moderate to Severe Ulcerative Colitis
Sep 9, 2025, 16:22 PM -
Targeted Review of mITT vs. ITT Data in CAR-T Submissions
Sep 9, 2025, 16:22 PM -
From the Outside Looking in: Patient Advocacy Groups' and Healthcare Providers' Perspectives on Patient Engagement Strategies in the Israeli Health Technology Assessment Process
Sep 9, 2025, 16:22 PM -
Unmet Need in IgA Nephropathy (IgAN): Disparity Between Clinical Guidelines and Real-World Practice in Ireland
Sep 9, 2025, 16:22 PM -
Bimekizumab’s Synergistic Economic Impact Across Four Indications in France
Sep 9, 2025, 16:22 PM -
Environmental Sustainability in HTA: To What Extent Are HTA Bodies Considering Environmental Considerations in Their Decision Making?
Sep 9, 2025, 16:22 PM -
Cost Comparison of Symptom Treatment in Atopic Dermatitis Using Upadacitinib and Dupilumab in Poland
Sep 9, 2025, 16:22 PM -
High All-Cause Hospitalization Among Those With Recurrent ASCVD Event: Evidence From a Large-Scale Real-World Database
Sep 9, 2025, 16:22 PM -
Biomarker Levels in Patients With Ulcerative Colitis Post-Advanced Therapy Induction: A Real-World Survey in Europe
Sep 9, 2025, 16:22 PM -
Utilization of Glucagon-Like Peptide-1 Receptor Agonists in the Irish Healthcare System
Sep 9, 2025, 16:22 PM -
Systems Simulation Methods for the Economic Evaluation of Non-Medicines and Nonsurgical Interventions: A Systematic Literature Review of Quality and Methods for Reproducing Complexity in Health and Health Behaviors
Sep 9, 2025, 16:22 PM -
Psychometric Evaluation of the Impact of Weight on Quality of Life–Lite Clinical Trials (IWQOL-Lite-CT) Version in Adults Participating in a Pharmacological Clinical Trial for Obesity
Sep 9, 2025, 16:22 PM -
Bayesian Network Meta-Analysis of Weight Loss Efficacy for GLP-1 Receptor Agonists and Tirzepatide
Sep 9, 2025, 16:22 PM -
Analysis of Clinical and Economic Evidence Focused on RWE in Medicare Drug Price Negotiations: Sacubitril/Valsartan, Rivaroxaban, and Apixaban
Sep 9, 2025, 16:22 PM -
Real-World Effectiveness, Safety Economic Impact, and Humanistic Outcomes of Bispecific Antibodies (BsAbs) in Third-or-Later-Line (3L+) Treatment of Relapsed/Refractory (R/R) Large B-cell Lymphoma (LBCL): A Systematic Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Are We Measuring What Matters in Postpartum Depression Trials?
Sep 9, 2025, 16:22 PM -
Common Criticism of Patient-Reported Outcomes (PRO) in Health Technology Assessments (HTA) by the Institute for Quality and Efficiency in Healthcare (IQWiG) in Breast Cancer and Non-Small Cell Lung Cancer (NSCLC)
Sep 9, 2025, 16:22 PM
